Addressing unmet needs in diabetic retinopathy
1Retina Associates of Cleveland; Case Western Reserve University School of Medicine/University Hospitals of Cleveland, Cleveland, OH.
The American Journal of Managed Care
|November 21, 2019
Summary
Diabetic retinopathy (DR) is a leading cause of vision loss. Early eye screenings for diabetes patients are crucial for timely diagnosis and treatment to prevent blindness and reduce economic impact.
Area of Science:
- Ophthalmology
- Endocrinology
- Public Health
Background:
- Diabetic retinopathy (DR) is a primary complication of diabetes mellitus, leading to vision impairment and blindness.
- It disproportionately affects working-age adults, causing significant productivity loss and reduced quality of life.
- Current adherence to recommended eye screening schedules among US adults with diabetes is below 50%.
Purpose of the Study:
- To emphasize the critical need for increased adherence to eye screening guidelines among diabetic patients.
- To highlight the importance of early detection and treatment in preventing vision loss from diabetic retinopathy.
- To underscore the substantial economic and personal costs associated with delayed diagnosis and treatment of DR.
Main Methods:
- This study is a review of existing literature and clinical guidelines concerning diabetic retinopathy.
- Analysis focuses on the consequences of delayed diagnosis and the benefits of early detection through regular eye screenings.
- The economic and social impact of vision impairment due to DR is examined.
Main Results:
- Early detection and treatment of DR can prevent 50% to 70% of associated blindness.
- Lack of early symptoms in DR often leads to delayed diagnosis until vision impairment is irreversible.
- Indirect costs of DR-related vision impairment, including lost productivity, far exceed direct medical expenses.
Conclusions:
- Improved adherence to eye screening guidelines is essential for prompt DR diagnosis and treatment.
- Early intervention can significantly reduce vision loss and the associated economic burden of diabetic retinopathy.
- Public health initiatives should focus on increasing screening rates to mitigate the impact of diabetes-related eye disease.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
817
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
817
Open Angle Glaucoma: Treatment
909
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
909
Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K


